Accumulation of versican and lack of versikine ameliorate acute colitis
Accumulation of versican and lack of versikine ameliorate acute colitis
复制标题
DOI:
10.1016/j.matbio.2022.02.004
复制
发表时间:
2022-02-24
期刊:
影响因子:
6.9
通讯作者:
Watanabe, Hideto
中科院分区:
文献类型:
--
作者:
Islam, Shamima;Jahan, Nushrat;Watanabe, Hideto
Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan that plays a key role in the formation of the provisional matrix. Here, we generated dextran sulfate sodium-induced colitis in knockin-mice, R/R, expressing ADAMTS-resistant versican, and investigated the impact of accumulating versican and its turnover in the inflammatory colon mucosa. Histologically, R/R colon showed decreased levels of tissue destruction and an increased number of myofibroblasts and macrophages. Characterization of inflammatory cells revealed an increase in F4/80+ macrophages in R/R colon, compared with wildtype, without a clear shift between M1 and M2 populations. Intestinal stroma exhibited a higher number of myofibroblasts in R/R, suggesting increased levels of tissue regeneration. Coculture of macrophages and stromal fibroblasts obtained from inflammatory colon showed that wild-type macrophages inhibited myofibroblastic differentiation of R/R fibroblasts but not wild-type. This inhibitory effect was due to an increased level of versikine, a cleaved fragment of versican by ADAMTS proteinases. Taken together, our results demonstrate versikine as the direct regulator that inhibits repair of inflamed tissue. (C) 2022 The Author(s). Published by Elsevier B.V.